Mitochondrial-Targeted Nanotherapy for Cancer Treatment

Mitochondrial-targeted nanotherapy harnesses the central role of mitochondria in cellular energy production, redox balance and apoptotic signalling to develop selective anticancer strategies. By engineering nanoscale carriers that accumulate within the mitochondrial matrix or membrane, researchers aim to disrupt tumour bioenergetics and elevate oxidative stress to trigger cancer cell death. Common design elements include lipophilic cations for membrane potential–driven uptake, pH-responsive coatings for tumour specificity and stimuli-responsive prodrug linkers that release therapeutics in situ. Such platforms have been adapted for chemotherapy, photodynamic and photothermal therapies, as well as for reversing drug resistance and enhancing radiotherapy. The convergence of targeting precision, controlled drug release and self-amplifying reactive oxygen species (ROS) generation underpins a new generation of multifunctional nanomedicines with the potential to improve efficacy while minimising systemic toxicity.

Research from Nature Portfolio

Recent studies have reported a dendritic lipopeptide liposomal system that mimics mitochondrial transmembrane proteins to achieve charge-reversible, pH-sensitive delivery of photothermal and photodynamic agents. This platform enhanced mitochondrial accumulation by nearly fourfold compared with conventional triphenylphosphonium-based systems and achieved complete tumour eradication in aggressive breast cancer models under combined light irradiation. Another key development involves dual-targeting polyprodrug nanoreactors covalently tethered with repeating camptothecin units that initially release drug in response to endogenous mitochondrial ROS. The liberated agent inhibits respiration, further amplifies ROS production and sustains a self-propagating cycle of drug release and oxidative collapse, driving apoptosis. Foundational work has also demonstrated lipid membrane-coated silica–carbon nanoparticles conjugated with pyruvate to selectively generate ROS under near-infrared irradiation, depleting ATP, downregulating efflux pumps and overcoming multidrug resistance for an extended therapeutic window.

Mitochondrial-Targeted Nanotherapy for Cancer Treatment publication trend

The graph below shows the total number of articles in mitochondrial-targeted nanotherapy for cancer treatment across all publications each year (not limited to Nature Index journals).

Technical terms

Mitochondrial membrane potential: The electrochemical gradient across the inner mitochondrial membrane that drives uptake of lipophilic cations.

Reactive oxygen species (ROS): Chemically reactive molecules derived from oxygen that can damage cellular components and trigger apoptosis when generated in excess.

Triphenylphosphonium (TPP): A lipophilic cation widely used to direct molecules to mitochondria by exploiting the organelle’s negative membrane potential.

Nanocarrier: A nanoscale delivery vehicle designed to encapsulate and transport therapeutic agents to specific cellular or subcellular targets.

Photodynamic therapy (PDT): A treatment modality that uses light-activated photosensitisers to generate ROS and induce cell death.

Chemodynamic therapy: An approach that leverages in situ chemical reactions, often via Fenton or Fenton-like processes, to produce cytotoxic ROS within tumours.

References

1. Unraveling mitochondria‐targeting reactive oxygen species modulation and their implementations in cancer therapy by nanomaterials. Exploration (2023).
2. Mitochondrial‐Targeted CS@KET/P780 Nanoplatform for Site‐Specific Delivery and High‐Efficiency Cancer Immunotherapy in Hepatocellular Carcinoma. Advanced Science (2024).
3. Mitochondria-specific drug release and reactive oxygen species burst induced by polyprodrug nanoreactors can enhance chemotherapy. Nature Communications (2019).
4. Mitochondrion-specific dendritic lipopeptide liposomes for targeted sub-cellular delivery. Nature Communications (2021).
5. A mitochondria-targeted nanoradiosensitizer activating reactive oxygen species burst for enhanced radiation therapy. Chemical Science (2018).